Domestic Pharma sales bounce back after two months of decline: Bloomberg

48 out of 50 companies showed “positive growth” in India’s pharmaceutical market for the month of July, AIOCD-AWACS data showed. Among the top 10 companies, GlaxoSmithKline Pharmaceuticals Ltd. showed the highest growth at 24.6 per cent followed by Alkem Laboratories Ltd. at 19.8 per cent and Mankind Pharma at 19.2 per cent. Among the companies ranked between 11 and 20, Aristo Pharma had the highest growth at 29.9 per cent, followed by Dr Reddy’s Laboratories Ltd. growing at 19.1 per cent and Emcure Pharmaceuticals at 18 per cent.

New Delhi: Domestic pharma sales bounced back in July after two falling for consecutive months as most therapies clocked double-digit growth rates.

Pharma sales grew at 13.2 per cent in July compared to 6.5 per cent in June, according to data released by AIOCD AWACS—a pharmaceutical market research firm. The growth was led by a 4.5 per cent volume growth, a 5.7 per cent price growth and a 2.9 per cent growth from new introductions.

This comes as a relief for the industry as the country’s pharmaceutical market grew at its slowest pace in five years in the quarter ended June because of a fall in volumes even as prices remained stable.

Sales in India’s pharmaceutical market in July 2019 were the highest in the last 32 months, according to Rakesh Nayudu, a pharma analyst at Haitong. The second quarter, Rayudu said, is seasonally better for the market.

Pharma volumes grew 4.5 per cent, highlighting a reversal from the decline of 0.6 per cent in June 2019, Edelweiss analyst Deepak Malik told BloombergQuint in an emailed response.

As per the data released by AIOCD-AWACS, respiratory therapies grew at 17.9 per cent, anti-infectives therapies grew at 16.1 per cent, cardio therapies grew at 13.3 per cent, gastro-intestinal therapies grew at 12.5 per cent, vitamins and minerals therapies grew at 12.3 per cent, central nervous system therapies grew at 11.3 per cent and dermatology therapies grew at 9.5 per cent.

Read Also: Export-focused domestic pharma companies need to step up regulatory compliance: Report

48 out of 50 companies showed “positive growth” in India’s pharmaceutical market for the month of July, AIOCD-AWACS data showed. Among the top 10 companies, GlaxoSmithKline Pharmaceuticals Ltd. showed the highest growth at 24.6 per cent followed by Alkem Laboratories Ltd. at 19.8 per cent and Mankind Pharma at 19.2 per cent. Among the companies ranked between 11 and 20, Aristo Pharma had the highest growth at 29.9 per cent, followed by Dr Reddy’s Laboratories Ltd. growing at 19.1 per cent and Emcure Pharmaceuticals at 18 per cent.

Among the smaller companies, JB Chemicals, Hetero, Indoco Remedies and Boehringer Ingelheim showed over 20 per cent growth.

Read Also: Oxytocin for domestic use to madatorily bear barcodes- Minister informs Parliament